Fulgent Genetics Announces Incremental Strategic Investment in Chinese Joint Venture, FF Gene Biotech

Investment gives Fulgent controlling ownership of its Chinese Joint Venture entity, FF Gene Biotech TEMPLE CITY, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “Company”), a technology company providing compr...

Full "IntellAsia: Resources" article